Prognostic value of combination of Cyfra 21-1, CEA and NSE in patients with advanced non-small cell lung cancer

This publication has 16 references indexed in Scilit:

• Prognostic Factors in Non-small Cell Lung Cancer
  Chest, 2002
• Serum carcinoembryonic antigen level in surgically resected clinical stage i patients with non-small cell lung cancer
  The Annals of Thoracic Surgery, 2002
• Prognostic impact of Cyfra21-1 and other serum markers in completely resected non-small cell lung cancer
  Lung Cancer, 2002
• Fuzzy logic-based tumor-marker profiles improved sensitivity in the diagnosis of lung cancer
  International Journal of Clinical Oncology, 2002
• Prognostic Value of Serum Tumor Markers in Patients with Lung Cancer
  Respiration, 2002
• The new World Health Organization classification of lung tumours
  European Respiratory Journal, 2001
• Serum Cyfra 21-1 as a co-variable in future NSCLC chemotherapy trials
  Lung Cancer, 2001
• Serum carcinoembryonic antigen as an adjunct to preoperative staging of lung cancer
  The Journal of Thoracic and Cardiovascular Surgery, 1998
• Pretreatment Evaluation of Non–Small-cell Lung Cancer
  American Journal of Respiratory and Critical Care Medicine, 1997
• CEA, CYFRA21-1 and SCC in non-small cell lung cancer
  Lung Cancer, 1995